Pharmidex attending Practical Application of Toxicology in Drug Development
July 11, 2016

Practical Application of Toxicology in Drug Development hosted by the American College of Toxicology and the British Toxicology Society

Meet the Pharmidex team at Practical Application of Toxicology in Drug Development

Practical Application of Toxicology in Drug Development hosted by the American College of Toxicology and the British Toxicology Society, Educational support provided by Charles River and Envigo. July 11th to July 15th at The Moller centre.


Please find more information on: http://www.actox.org/meetCourses/patdd2016.asp

January 29, 2026
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
January 26, 2026
Pharmidex provides comprehensive biomarker and cytokine profiling services to support drug discovery and development across respiratory, autoimmune, metabolic and toxicology programmes. Using state-of-the-art bioanalytical platforms, we deliver robust, translational biomarker data to help understand mechanism of action, immune modulation and therapeutic efficacy. Let’s talk about how our biomarker expertise can strengthen your research. 🌐 https://www.pharmidex.com/BIOMARKERS_ANALYSIS
January 21, 2026
We’re delighted to share that Vasudha Tandon, PhD Principal Scientist at Pharmidex , will be attending the BBMS Gala Dinner 2026 on Thursday 22 January 2026 at the Old Hall, Queens’ College, Cambridge. This special evening, part of Building Bridges in Medical Sciences, brings together leaders from academia, industry, and healthcare to strengthen collaboration across the life sciences. Vasudha is looking forward to meeting fellow attendees and exploring new opportunities to build meaningful scientific partnerships.
More Posts